CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	7 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 28, 2017	Dec. 29, 2016	May 28, 2015
OPERATING ACTIVITIES
Net earnings	$ 23,443	$ 64,485	$ 37,539	$ 23,642
Adjustments to reconcile net earnings to net cash provided by operating activities:
Losses (earnings) on investments in joint ventures	36	(46)	(301)	186
Distributions from joint ventures	152	377	560	166
Loss (gain) on disposition of property, equipment and other assets	490	(3,981)	844	1,463
Impairment charge	0	0	0	2,919
Amortization of favorable lease right	194	334	334	334
Depreciation and amortization	23,815	51,719	41,832	38,361
Amortization of debt issuance costs	258	308	303	449
Share-based compensation	975	2,411	1,899	1,499
Deferred income taxes	(1,079)	(6,438)	3,022	5,614
Deferred compensation and other	1,564	911	577	3,531
Contribution of the Company’s stock to savings and profit-sharing plan	0	1,024	905	888
Changes in operating assets and liabilities:
Accounts and notes receivable	2,967	(8,852)	(1,486)	(5,627)
Other current assets	(388)	(2,268)	(2,465)	(845)
Accounts payable	(665)	15,015	(1,978)	2,355
Income taxes	7,567	(13,663)	(5,124)	(925)
Taxes other than income taxes	2,550	2,377	(373)	766
Accrued compensation	(3,085)	(1,380)	4,738	2,440
Other accrued liabilities	8,016	6,703	1,829	3,236
Total adjustments	43,367	44,551	45,116	56,810
Net cash provided by operating activities	66,810	109,036	82,655	80,452
INVESTING ACTIVITIES
Capital expenditures	(44,452)	(114,804)	(83,606)	(74,988)
Purchase of theatres, net of cash acquired and working capital assumed	0	0	(63,766)	0
Proceeds from disposals of property, equipment and other assets	13,977	4,524	1,560	226
Decrease (increase) in restricted cash	(9,259)	967	12,553	(728)
Decrease (increase) in other assets	495	911	3,572	(786)
Capital contribution in joint venture	0	(111)	0	(399)
Purchase of interest in joint venture	(1,600)	0	0	(1,500)
Contribution received from local government	0	1,545	0	0
Proceeds from sale of interests in joint ventures	0	6,729	1,100	0
Net cash used in investing activities	(40,839)	(100,239)	(128,587)	(78,175)
Debt transactions:
Proceeds from borrowings on revolving credit facility	108,500	322,000	346,188	162,500
Repayment of borrowings on revolving credit facility	(126,500)	(332,000)	(236,188)	(148,500)
Proceeds from issuance of long-term debt	0	65,000	0	0
Principal payments on long-term debt	(3,339)	(36,300)	(52,335)	(7,176)
Principal payments on capital lease obligations	0	(1,986)	0	0
Debt issuance costs	0	(418)	(578)	0
Equity transactions:
Treasury stock transactions, except for stock options	594	(421)	(6,089)	(773)
Exercise of stock options	860	2,271	3,986	2,964
Dividends paid	(5,632)	(13,504)	(12,037)	(10,390)
Distributions to noncontrolling interest	(505)	(20)	(448)	(959)
Purchase of noncontrolling interest	0	(410)	0	0
Net cash provided by (used in) financing activities	(26,022)	4,212	42,499	(2,334)
Net increase (decrease) in cash and cash equivalents	(51)	13,009	(3,433)	(57)
Cash and cash equivalents at beginning of year	6,723	3,239	6,672	6,780
Cash and cash equivalents at end of year	6,672	16,248	3,239	6,723
Supplemental Information:
Change in accounts payable for additions to property and equipment	(7,370)	5,320	3,417	3,467
Capital leases acquired	0	6,173	17,511	0
Capital lease extensions	0	3,675	0	0
Non-cash contribution in joint venture	$ 400	$ 0	$ 0	$ 0